Tags

Type your tag names separated by a space and hit enter

[New guidelines on functional and somatoform disorders].

Abstract

The S3 guideline "Dealing with patients with non-specific, functional and somatoform bodily symptoms" emphasizes the similarities in the management of the manifold manifestations of so called "medically unexplained symptoms" and gives recommendations for a stepped and collaborative diagnostic and therapeutic approach in all subspecialties and all levels of health care. It has a special focus on recommendations regarding attitude, physician-patient-relationship, communication, the parallelization of somatic and psychosocial diagnostics and a stepped therapeutic approach. The "Evidence-based guideline psychotherapy in somatoform disorders and associated syndromes" provides a differentiated analysis of the current evidence regarding the effectiveness of various psychotherapeutic interventions for the most relevant manifestations of functional and somatoform disorders. In combination, both guidelines pose important advances for treatment quality in Germany, but also illustrate remarkable structural and research deficits.

Authors+Show Affiliations

Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Technische Universität München. c.hausteiner-wiehle@tum.deNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

ger

PubMed ID

23341111

Citation

Hausteiner-Wiehle, Constanze, et al. "[New Guidelines On Functional and Somatoform Disorders]." Psychotherapie, Psychosomatik, Medizinische Psychologie, vol. 63, no. 1, 2013, pp. 26-31.
Hausteiner-Wiehle C, Schäfert R, Sattel H, et al. [New guidelines on functional and somatoform disorders]. Psychother Psychosom Med Psychol. 2013;63(1):26-31.
Hausteiner-Wiehle, C., Schäfert, R., Sattel, H., Ronel, J., Herrmann, M., Häuser, W., ... Henningsen, P. (2013). [New guidelines on functional and somatoform disorders]. Psychotherapie, Psychosomatik, Medizinische Psychologie, 63(1), pp. 26-31. doi:10.1055/s-0032-1323743.
Hausteiner-Wiehle C, et al. [New Guidelines On Functional and Somatoform Disorders]. Psychother Psychosom Med Psychol. 2013;63(1):26-31. PubMed PMID: 23341111.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [New guidelines on functional and somatoform disorders]. AU - Hausteiner-Wiehle,Constanze, AU - Schäfert,Rainer, AU - Sattel,Heribert, AU - Ronel,Joram, AU - Herrmann,Markus, AU - Häuser,Winfried, AU - Martin,Alexandra, AU - Henningsen,Peter, Y1 - 2013/01/22/ PY - 2013/1/24/entrez PY - 2013/1/24/pubmed PY - 2013/12/16/medline SP - 26 EP - 31 JF - Psychotherapie, Psychosomatik, medizinische Psychologie JO - Psychother Psychosom Med Psychol VL - 63 IS - 1 N2 - The S3 guideline "Dealing with patients with non-specific, functional and somatoform bodily symptoms" emphasizes the similarities in the management of the manifold manifestations of so called "medically unexplained symptoms" and gives recommendations for a stepped and collaborative diagnostic and therapeutic approach in all subspecialties and all levels of health care. It has a special focus on recommendations regarding attitude, physician-patient-relationship, communication, the parallelization of somatic and psychosocial diagnostics and a stepped therapeutic approach. The "Evidence-based guideline psychotherapy in somatoform disorders and associated syndromes" provides a differentiated analysis of the current evidence regarding the effectiveness of various psychotherapeutic interventions for the most relevant manifestations of functional and somatoform disorders. In combination, both guidelines pose important advances for treatment quality in Germany, but also illustrate remarkable structural and research deficits. SN - 1439-1058 UR - https://www.unboundmedicine.com/medline/citation/23341111/ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-0032-1323743 DB - PRIME DP - Unbound Medicine ER -